Acute promyelocytic leukemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Category)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Acute promyelocytic leukemia}}
{{Acute promyelocytic leukemia}}
{{CMG}}
{{CMG}} {{shyam}}
==Epidemiology and Demographics==
==Epidemiology and Demographics==
Acute promyelocytic leukemia represents 5-8% of AML in adults. The median age is approximately 40 years, which is considerably younger than the other subtypes of AML (70 years). The incidence is increased in patients originated in Latin American countries.(Douer ''et al.'')
Acute promyelocytic leukemia represents 10-15%% of all cases of acute myeloid leukemia in adults.<ref name="pmid29541170">{{cite journal| author=Chen C, Huang X, Wang K, Chen K, Gao D, Qian S| title=Early mortality in acute promyelocytic leukemia: Potential predictors. | journal=Oncol Lett | year= 2018 | volume= 15 | issue= 4 | pages= 4061-4069 | pmid=29541170 | doi=10.3892/ol.2018.7854 | pmc=5835847 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29541170  }} </ref> The median age is approximately 40 years, which is considerably younger than the other subtypes of acute myeloid leukemia (70 years). The incidence is increased in patients originated in Latin American countries.  


==References==
==References==

Revision as of 16:24, 12 May 2018

Acute promyelocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute promyelocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary PreventionSurgery

Secondary PreventionSurgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute promyelocytic leukemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute promyelocytic leukemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute promyelocytic leukemia epidemiology and demographics

CDC on Acute promyelocytic leukemia epidemiology and demographics

Acute promyelocytic leukemia epidemiology and demographics in the news

Blogs on Acute promyelocytic leukemia epidemiology and demographics

Directions to Hospitals Treating Acute promyelocytic leukemia

Risk calculators and risk factors for Acute promyelocytic leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Epidemiology and Demographics

Acute promyelocytic leukemia represents 10-15%% of all cases of acute myeloid leukemia in adults.[1] The median age is approximately 40 years, which is considerably younger than the other subtypes of acute myeloid leukemia (70 years). The incidence is increased in patients originated in Latin American countries.

References

  1. Chen C, Huang X, Wang K, Chen K, Gao D, Qian S (2018). "Early mortality in acute promyelocytic leukemia: Potential predictors". Oncol Lett. 15 (4): 4061–4069. doi:10.3892/ol.2018.7854. PMC 5835847. PMID 29541170.

Template:WH Template:WS